Metformina Azevedos

Metformin Hydrochloride, the active ingredient in Metformina Azevedos, is a biguanide presented as an oral dosage form for oral use. It is used to lower elevated blood glucose levels in adults with type 2 diabetes mellitus and related insulin‑resistant conditions.

GNH USA supplies Metformina Azevedos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformina Azevedos, a biguanide antidiabetic, is employed in metabolic disorders that involve insulin resistance. - Type 2 diabetes mellitus: improves glycaemic control by reducing hepatic glucose output and enhancing peripheral insulin sensitivity. - Impaired glucose tolerance (prediabetes): helps delay progression to overt diabetes through improved insulin action. - Polycystic ovary syndrome: assists in normalising metabolic parameters and reducing hyperinsulinaemia.

Metformina Azevedos may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhoea: frequent loose stools, especially at treatment initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hypoglycaemia: when combined with other glucose‑lowering agents. - Hepatic dysfunction: rare liver enzyme elevations. - Vitamin B12 deficiency: may develop with long‑term use. - Renal impairment: worsening kidney function in susceptible patients.

Metformina Azevedos requires careful patient assessment and monitoring. - Renal function assessment: evaluate eGFR before initiating therapy and periodically thereafter. - Lactic acidosis risk: avoid in patients with severe renal or hepatic impairment. - Alcohol consumption: limit intake as it may increase lactate production. - Monitoring: regular measurement of blood glucose, HbA1c, and renal parameters. - Vitamin B12 levels: consider periodic testing during long‑term treatment. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metformina Azevedos can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise plasma metformin concentrations. - Chronic alcohol abuse: heightens the chance of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Thiazide diuretics: can attenuate glucose‑lowering effect. - ACE inhibitors or ARBs: require monitoring of renal function and electrolytes.